Recent studies have demonstrated that CIS activates TLR4 in different models, such as testicular (Hassanein et al. 2021), renal (Deng et al. 2020), and hepatic (Khedr et al. 2020) injuries. The gene discussed is TLR4; the disease is in situ carcinoma.